Hybrid Exec Director, Clinical Research - Neurodegeneration

Alnylam Pharmaceuticals, Inc.

Maidenhead

Hybrid

GBP 189,000 - 303,000

Full time

3 days ago
Be an early applicant

A complete application in a minute

Tailored resume and cover letter, ready to send.

Get past ATS filters

Job summary

Alnylam Pharmaceuticals, Inc. is seeking an Executive Director, Clinical Research in Neurodegeneration to lead clinical development programs, primarily Huntington’s disease, and influence overall development strategies.

The role requires collaboration across Regulatory, Biostatistics, Clinical Operations, and Medical Affairs in a matrix organization. The position is hybrid with weekly onsite presence and can be based in Cambridge, MA or Maidenhead, UK, with relocation possible.

Qualifications

  • MD with strong research background and peer‑reviewed publications.
  • 10+ years industry or clinical academic experience.
  • Experience leading Phase 2/3 programs and regulatory interactions.
  • Familiarity with biostatistics, regulatory guidelines, and trial design.

Responsibilities

  • Be the strategic leader providing a strong voice for clinical programs.
  • Lead drug development approaches to secure global regulatory approvals.
  • Oversee trial conduct and safety.
  • Provide strategic guidance to Research on clinical development feasibility.
  • Collaborate with Regulatory, Medical, and Commercial teams for integrated plans.
  • Ensure timely deliverables and high‑impact documentation.

Skills

Clinical leadership
Strategic thinking
Medical doctor
Regulatory engagement
Communication
Presentation skills
Collaboration

Education

MD/MD-PhD
Board certification
Neurology/ Huntington’s experience

Job description

Alnylam Pharmaceuticals, Inc. is seeking an Executive Director, Clinical Research in Neurodegeneration to lead clinical development programs, primarily Huntington’s disease, and influence overall development strategies.

The role requires collaboration across Regulatory, Biostatistics, Clinical Operations, and Medical Affairs in a matrix organization. The position is hybrid with weekly onsite presence and can be based in Cambridge, MA or Maidenhead, UK, with relocation possible.

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Executive Director, Clinical Research - Neurodegeneration
Executive Director, Clinical Research - Neurodegeneration

Alnylam Pharmaceuticals, Inc. • Maidenhead

Hybrid
GBP 189,000 - 303,000
Director, Clinical Research- Benign Hematology
Director, Clinical Research- Benign Hematology

Alnylam • Maidenhead

On-site
GBP 90,000 - 180,000
Director, Clinical Research — RNAi Therapeutics Lead
Director, Clinical Research — RNAi Therapeutics Lead

Alnylam Pharmaceuticals, Inc. • Maidenhead

On-site
GBP 190,000 - 258,000
Strategic Director, Clinical Research — RNAi Therapeutics
Strategic Director, Clinical Research — RNAi Therapeutics

Alnylam • Maidenhead

On-site
GBP 90,000 - 180,000
Director, Clinical Research- Benign Hematology
Director, Clinical Research- Benign Hematology

Alnylam Pharmaceuticals, Inc. • Maidenhead

On-site
GBP 190,000 - 258,000
Director, Clinical Research — RNAi Therapeutics Lead (Phase 2–3)
Director, Clinical Research — RNAi Therapeutics Lead (Phase 2–3)

Alnylampharmaceuticals • Cambridge, Maidenhead

On-site
GBP 190,000 - 258,000
Director, Clinical Research- Benign Hematology
Director, Clinical Research- Benign Hematology

Alnylampharmaceuticals • Cambridge, Maidenhead

On-site
GBP 190,000 - 258,000
Senior Biostatistics Lead, Clinical Trials (Hybrid)
Senior Biostatistics Lead, Clinical Trials (Hybrid)

Alnylam Pharmaceuticals, Inc. • Maidenhead

Hybrid
GBP 120,000 - 160,000
Senior Biostatistics Lead — Hybrid
Senior Biostatistics Lead — Hybrid

Alnylam Pharmaceuticals, Inc. • Maidenhead

Hybrid
GBP 95,000 - 140,000
Director, Translational Neurodegeneration (Hybrid)
Director, Translational Neurodegeneration (Hybrid)

Novartis AG • Greater London

Hybrid
GBP 96,000 - 178,000
Insurance plans
Retirement plans
Wellbeing resources
+2